Synbio Tech Inc. (TPEX:1295)
Taiwan · Delayed Price · Currency is TWD 50.10
-0.10 (-0.20%)
Oct 8, 2026, 1:30 PM CST
Synbio Tech Revenue
Synbio Tech had revenue of 296.17M TWD in the quarter ending June 30, 2026, a decrease of -4.19%. This brings the company's revenue in the last twelve months to 1.01B, down -5.28% year-over-year. In the year 2025, Synbio Tech had annual revenue of 1.04B with 4.97% growth. That makes Synbio Tech the 31,027th largest company in the world by revenue and 1,561st in Taiwan.
Revenue (ttm)
1.01B
Revenue Growth
-5.28%
P/S Ratio
1.72
Revenue / Employee
10.94M
Employees
92
Market Cap
1.73B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.04B | 49.19M | 4.97% |
| Dec 31, 2024 | 989.48M | 166.18M | 20.18% |
| Dec 31, 2023 | 823.30M | 83.98M | 11.36% |
| Dec 31, 2022 | 739.33M | -116.46M | -13.61% |
| Dec 31, 2021 | 855.79M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Syngen Biotech | 2.05B |
| GenMont Biotech Incorporation | 382.11M |
| Abnova (Taiwan) | 345.45M |
| Sunny Pharmtech | 233.36M |
| G&E Herbal Biotechnology | 215.61M |
| TaiRx | 29.44M |
| Anti-Microbial Savior BioteQ | 1.26M |